NO20031694L - Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament - Google Patents

Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament

Info

Publication number: NO20031694L
Authority: NO; Norway
Prior art keywords: drug; manufacture; preparation; crystalline monohydrate; monohydrate
Prior art date: 2000-10-12

Application number

NO20031694A

Other languages

English (en)

Other versions

NO328465B1 (no

NO20031694D0 (no

Inventor

Rolf Banholzer

Manfred Graulich

Christian Kulinna

Andreas Mathes

Helmut Meissner

Peter Sieger

Peter Specht

Michael Trunk

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-12

Filing date

2003-04-11

Publication date

2003-04-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031694(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-04-11 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2003-04-11 Publication of NO20031694D0 publication Critical patent/NO20031694D0/no

2003-04-11 Publication of NO20031694L publication Critical patent/NO20031694L/no

2010-02-22 Publication of NO328465B1 publication Critical patent/NO328465B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20031694A 2000-10-12 2003-04-11 Krystallinsk monohydrat, fremgangsmate for fremstilling derav og anvendelse derav til fremstilling av et medikament NO328465B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10050621		2000-10-12
PCT/EP2001/011225 WO2002030928A1 (de)	2000-10-12	2001-09-28	Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels

Publications (3)

Publication Number	Publication Date
NO20031694D0 NO20031694D0 (no)	2003-04-11
NO20031694L true NO20031694L (no)	2003-04-11
NO328465B1 NO328465B1 (no)	2010-02-22

Family

ID=7659568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031694A NO328465B1 (no)	2000-10-12	2003-04-11	Krystallinsk monohydrat, fremgangsmate for fremstilling derav og anvendelse derav til fremstilling av et medikament

Country Status (46)

Country	Link
EP (2)	EP1326862B1 (no)
JP (1)	JP3764422B2 (no)
KR (1)	KR100823860B1 (no)
CN (2)	CN1221549C (no)
AP (1)	AP1572A (no)
AR (2)	AR034389A1 (no)
AT (1)	ATE276253T1 (no)
AU (2)	AU1499602A (no)
BG (1)	BG66161B1 (no)
BR (1)	BR0114584A (no)
CA (1)	CA2425539C (no)
CR (1)	CR6938A (no)
CZ (1)	CZ301841B6 (no)
DE (1)	DE50103666D1 (no)
DK (1)	DK1326862T3 (no)
DZ (1)	DZ3478A1 (no)
EA (1)	EA004381B1 (no)
EC (1)	ECSP034540A (no)
EE (1)	EE04567B1 (no)
EG (1)	EG24142A (no)
ES (1)	ES2228965T3 (no)
GE (1)	GEP20063905B (no)
HR (1)	HRP20030276B1 (no)
HU (1)	HU226830B1 (no)
IL (2)	IL155335A0 (no)
IS (1)	IS2339B (no)
MA (1)	MA25842A1 (no)
ME (2)	MEP40008A (no)
MX (1)	MXPA03003221A (no)
MY (1)	MY126931A (no)
NO (1)	NO328465B1 (no)
NZ (1)	NZ525733A (no)
OA (1)	OA12403A (no)
PE (1)	PE20020422A1 (no)
PL (1)	PL207870B1 (no)
PT (1)	PT1326862E (no)
RS (1)	RS50218B (no)
SA (1)	SA01220412B1 (no)
SI (1)	SI1326862T1 (no)
SK (1)	SK287009B6 (no)
TR (1)	TR200402579T4 (no)
TW (1)	TW589313B (no)
UA (1)	UA74215C2 (no)
UY (2)	UY26962A1 (no)
WO (1)	WO2002030928A1 (no)
ZA (1)	ZA200302500B (no)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6608055B2 (en)	2001-06-22	2003-08-19	Boehringer Ingelheim Pharma Kg	Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
EP1401445B1 (de) *	2001-06-22	2006-08-23	Boehringer Ingelheim Pharma GmbH & Co.KG	Kristallines anticholinergikum, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
DE10212264A1 (de)	2002-03-20	2003-10-02	Boehringer Ingelheim Pharma	Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7311894B2 (en)	2002-03-28	2007-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations containing an anticholinergic
US7244415B2 (en)	2002-03-28	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations of an anhydrate
DE10214263A1 (de) *	2002-03-28	2003-10-16	Boehringer Ingelheim Pharma	HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de)	2003-04-16	2004-10-28	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
CN102070630B (zh) *	2003-11-03	2013-04-17	贝林格尔.英格海姆国际有限公司	结晶噻托碘铵、包含该结晶噻托碘铵的药物制剂及其用途
EP1682543B1 (de) *	2003-11-03	2010-08-18	Boehringer Ingelheim International Gmbh	Verfahren zur herstellung neuer tiotropiumsalze
US7968717B2 (en)	2003-11-03	2011-06-28	Boehringer Ingelhein International Gmbh	Crystalline anhydrate with anticholinergic efficacy
ME00349B (me) *	2003-11-03	2011-05-10	Boehringer Ingelheim Int	Novi kristalni anhidrat sa antiholinergij skim dejstvom
DE102004016179A1 (de) *	2004-03-30	2005-10-20	Boehringer Ingelheim Pharma	Verbindungen zur Behandlung von proliferativen Prozessen
EA013157B1 (ru)	2004-04-22	2010-02-26	Бёрингер Ингельхайм Интернациональ Гмбх	Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
DE102004024454A1 (de)	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2322148T3 (es)	2004-08-11	2009-06-17	BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG	Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20060079544A1 (en) *	2004-08-13	2006-04-13	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de)	2004-10-01	2006-04-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
WO2006045715A1 (de) *	2004-10-21	2006-05-04	Boehringer Ingelheim International Gmbh	Blister für inhalatoren
WO2006094924A2 (en) *	2005-03-09	2006-09-14	Boehringer Ingelheim International Gmbh	New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
JP5053997B2 (ja)	2005-04-28	2012-10-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	炎症性疾患の治療用の新規化合物
CA2606549A1 (en)	2005-05-02	2006-11-09	Boehringer Ingelheim International Gmbh	Crystalline forms of tiotropium bromide
CN101203513A (zh) *	2005-05-02	2008-06-18	贝林格尔·英格海姆国际有限公司	噻托溴铵的晶型
NZ564697A (en) *	2005-06-15	2010-04-30	Boehringer Ingelheim Int	Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005030733A1 (de)	2005-07-01	2007-01-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
WO2007017438A1 (en) *	2005-08-06	2007-02-15	Boehringer Ingelheim International Gmbh	Use of tiotropium salts in the treatment of severe persistant asthma
CN101208316B (zh)	2005-08-15	2012-05-09	贝林格尔·英格海姆国际有限公司	制备β-模拟物的方法
TWI396541B (zh) *	2005-10-10	2013-05-21	Boehringer Ingelheim Int	用於治療呼吸疾病之新穎藥物組合
US7423146B2 (en)	2005-11-09	2008-09-09	Boehringer Ingelheim International Gmbh	Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
DE102005059602A1 (de)	2005-12-14	2007-06-21	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Mikronisierung
CN102731494A (zh)	2005-12-19	2012-10-17	西科尔公司	噻托溴铵的新形式及其制备方法
EP1966196A2 (en) *	2005-12-19	2008-09-10	Sicor, Inc.	Pure and stable tiotropium bromide
EP1971332B1 (en) *	2006-01-04	2011-03-09	Boehringer Ingelheim International GmbH	Use of tiotropium salts in the treatment of moderate persistent asthma
EP1874781B9 (de)	2006-04-19	2010-09-08	Boehringer Ingelheim International GmbH	Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
EP1847543A1 (de)	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
US20080051582A1 (en)	2006-07-10	2008-02-28	Sicor Inc.	Process for the preparation of tiotropium bromide
ES2360963T3 (es)	2006-08-07	2011-06-10	Boehringer Ingelheim International Gmbh	Combinaciones de fármacos para el tratamiento de enfermedades de las vías respiratorias.
PE20080610A1 (es)	2006-08-22	2008-07-15	Boehringer Ingelheim Int	Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos
EP1923393A1 (en) *	2006-11-17	2008-05-21	Boehringer Ingelheim Pharma GmbH & Co. KG	Crystalline form of tiotropium bromide and urea
EP1925295A1 (de) *	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Stabile Pulverformulierung enthaltend ein Anticholinergikum
GB0716026D0 (en) *	2007-08-16	2007-09-26	Norton Healthcare Ltd	An inhalable medicament
WO2009050248A1 (de)	2007-10-19	2009-04-23	Boehringer Ingelheim International Gmbh	Substituierte piperidino-dihydrothienopyrimidine
EP2093219A1 (de)	2008-02-22	2009-08-26	Boehringer Ingelheim International Gmbh	Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
US20100272811A1 (en) *	2008-07-23	2010-10-28	Alkermes,Inc.	Complex of trospium and pharmaceutical compositions thereof
KR101754698B1 (ko)	2008-12-19	2017-07-26	센트렉시온 테라퓨틱스 코포레이션	염증, 천식 및 ｃｏｐｄ 치료용 ｃｃｒ2 수용체 길항제로서의 사이클릭 피리미딘-4-카복스아미드
EP2201934A1 (en)	2008-12-23	2010-06-30	CHIESI FARMACEUTICI S.p.A.	Tiotropium aerosol formulation products with improved chemical stability
WO2010101538A2 (en)	2009-03-06	2010-09-10	Bilgic Mahmut	New crystal forms
WO2011015883A1 (en)	2009-08-07	2011-02-10	Generics [Uk] Limited	Dichloromethane solvate of tiotropium bromide and its use
US8697719B2 (en)	2009-08-07	2014-04-15	Generics [Uk] Limited	Anhydrate of tiotropium bromide
HRP20141143T1 (hr)	2009-12-17	2015-01-02	Boehringer Ingelheim International Gmbh	Novi antagonisti receptora ccr2 i njihove uporabe
JP5658272B2 (ja)	2009-12-17	2015-01-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｃｒ２の新規アンタゴニスト及びこれらの使用
MX2012008533A (es)	2010-01-29	2012-08-31	Boehringer Ingelheim Int	Naftiridinas sustituidas y su uso como inhibidores de syk quinasa.
US8946218B2 (en)	2010-05-12	2015-02-03	Boehringer Ingelheim International Gmbh	CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
WO2011141474A1 (en)	2010-05-12	2011-11-17	Boehringer Ingelheim International Gmbh	Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
EP2571870B1 (en)	2010-05-17	2015-01-21	Boehringer Ingelheim International GmbH	Ccr2 antagonists and uses thereof
EP2576542B1 (en)	2010-05-25	2015-04-22	Boehringer Ingelheim International GmbH	Cyclic amide derivatives of pyridazine-3-carboxylic acids and their use in the treatment of pulmonary, pain, immune related and cardiovascular diseases
JP5721242B2 (ja)	2010-06-01	2015-05-20	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規ｃｃｒ２アンタゴニスト
JP5959537B2 (ja)	2011-01-28	2016-08-02	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	置換ピリジニル−ピリミジン及び医薬としてのその使用
TR201102068A2 (tr)	2011-03-03	2012-09-21	Bi̇lgi̇ç Mahmut	Tiotropyum bromür içeren kristal maddeler
WO2012171863A1 (en)	2011-06-16	2012-12-20	Boehringer Ingelheim International Gmbh	New selective ccr2 antagonists
WO2013010839A1 (en)	2011-07-15	2013-01-24	Boehringer Ingelheim International Gmbh	Novel and selective ccr2 antagonists
WO2013014060A1 (en)	2011-07-26	2013-01-31	Boehringer Ingelheim International Gmbh	Substituted quinolines and their use as medicaments
US20130059866A1 (en)	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CZ304368B6 (cs) *	2011-11-28	2014-04-02	Zentiva, K.S.	Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en)	2011-12-19	2012-02-29	Teva Branded Pharmaceutical Prod R & D Inc	An inhalable medicament
US9096579B2 (en)	2012-04-20	2015-08-04	Boehringer Ingelheim International Gmbh	Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
ES2620758T3 (es)	2012-11-05	2017-06-29	Zentiva K.S.	Estabilización de solvatos de tiotropio
EP2913332A1 (en) *	2014-02-27	2015-09-02	Euticals S.P.A.	Crystalline form of tiotropium bromide with lactose
MX2016011784A (es)	2014-03-19	2016-12-02	Boehringer Ingelheim Int	Nuevos heteroarilos y su uso como medicamentos.
US10034866B2 (en)	2014-06-19	2018-07-31	Teva Branded Pharmaceutical Products R&D, Inc.	Inhalable medicament comprising tiotropium
RU2567539C1 (ru) *	2015-02-04	2015-11-10	Индивидуальный предприниматель Михайлов Олег Ростиславович	КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ
EP3414243A1 (en)	2016-02-11	2018-12-19	Sima Patent Ve Lisanslama Hizmetleri Ltd. STI	Crystalline form of tiotropium bromide anhydrate
WO2018084817A2 (en) *	2016-11-04	2018-05-11	Si̇ma Patent Ve Li̇sanslama Hi̇zmetleri̇ Ltd. Şti̇	A new form of active agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931041C2 (de) *	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
WO1994013263A1 (en) *	1992-12-09	1994-06-23	Jager Paul D	Stabilized medicinal aerosol solution formulations
DE19834506A1 (de) *	1998-07-31	2000-02-03	Hexal Ag	Transmucosales therapeutisches System zur Anwendung von Sildenafil
EP1102579B1 (de) *	1998-08-04	2003-03-19	Jago Research Ag	Medizinische aerosolformulierungen

2001
- 2001-09-28 ES ES01983510T patent/ES2228965T3/es not_active Expired - Lifetime
- 2001-09-28 HU HU0301022A patent/HU226830B1/hu unknown
- 2001-09-28 AP APAP/P/2003/002775A patent/AP1572A/en active
- 2001-09-28 KR KR1020037005083A patent/KR100823860B1/ko not_active Expired - Lifetime
- 2001-09-28 OA OA1200300107A patent/OA12403A/fr unknown
- 2001-09-28 SK SK436-2003A patent/SK287009B6/sk not_active IP Right Cessation
- 2001-09-28 GE GE5214A patent/GEP20063905B/en unknown
- 2001-09-28 EP EP01983510A patent/EP1326862B1/de not_active Expired - Lifetime
- 2001-09-28 CA CA002425539A patent/CA2425539C/en not_active Expired - Lifetime
- 2001-09-28 DK DK01983510T patent/DK1326862T3/da active
- 2001-09-28 PL PL366041A patent/PL207870B1/pl unknown
- 2001-09-28 CN CNB018171435A patent/CN1221549C/zh not_active Ceased
- 2001-09-28 AU AU1499602A patent/AU1499602A/xx active Pending
- 2001-09-28 EA EA200300457A patent/EA004381B1/ru not_active IP Right Cessation
- 2001-09-28 RS YU27303A patent/RS50218B/sr unknown
- 2001-09-28 CZ CZ20031025A patent/CZ301841B6/cs not_active IP Right Cessation
- 2001-09-28 PT PT01983510T patent/PT1326862E/pt unknown
- 2001-09-28 IL IL15533501A patent/IL155335A0/xx active IP Right Grant
- 2001-09-28 CN CNB2005100977370A patent/CN100519558C/zh not_active Ceased
- 2001-09-28 MX MXPA03003221A patent/MXPA03003221A/es active IP Right Grant
- 2001-09-28 TR TR2004/02579T patent/TR200402579T4/xx unknown
- 2001-09-28 WO PCT/EP2001/011225 patent/WO2002030928A1/de not_active Ceased
- 2001-09-28 BR BR0114584-3A patent/BR0114584A/pt not_active Application Discontinuation
- 2001-09-28 UA UA2003054185A patent/UA74215C2/uk unknown
- 2001-09-28 JP JP2002534314A patent/JP3764422B2/ja not_active Expired - Lifetime
- 2001-09-28 DE DE50103666T patent/DE50103666D1/de not_active Expired - Lifetime
- 2001-09-28 NZ NZ525733A patent/NZ525733A/en not_active IP Right Cessation
- 2001-09-28 SI SI200130219T patent/SI1326862T1/xx unknown
- 2001-09-28 EP EP04016877A patent/EP1468998A1/de not_active Withdrawn
- 2001-09-28 ME MEP-400/08A patent/MEP40008A/xx unknown
- 2001-09-28 EE EEP200300171A patent/EE04567B1/xx unknown
- 2001-09-28 DZ DZ013478A patent/DZ3478A1/fr active
- 2001-09-28 AU AU2002214996A patent/AU2002214996B2/en not_active Expired
- 2001-09-28 AT AT01983510T patent/ATE276253T1/de active
- 2001-09-28 HR HR20030276A patent/HRP20030276B1/xx not_active IP Right Cessation
- 2001-09-28 ME MEP-2008-400A patent/ME00243B/me unknown
- 2001-10-02 SA SA01220412A patent/SA01220412B1/ar unknown
- 2001-10-09 EG EG20011058A patent/EG24142A/xx active
- 2001-10-09 TW TW090124963A patent/TW589313B/zh active
- 2001-10-10 PE PE2001001000A patent/PE20020422A1/es active IP Right Grant
- 2001-10-10 UY UY26962A patent/UY26962A1/es not_active Application Discontinuation
- 2001-10-10 MY MYPI20014705A patent/MY126931A/en unknown
- 2001-10-12 AR ARP010104782A patent/AR034389A1/es active IP Right Grant
2003
- 2003-03-26 CR CR6938A patent/CR6938A/es unknown
- 2003-03-28 BG BG107687A patent/BG66161B1/bg unknown
- 2003-03-31 ZA ZA200302500A patent/ZA200302500B/en unknown
- 2003-04-07 EC EC2003004540A patent/ECSP034540A/es unknown
- 2003-04-08 MA MA27102A patent/MA25842A1/fr unknown
- 2003-04-09 IS IS6772A patent/IS2339B/is unknown
- 2003-04-10 IL IL155335A patent/IL155335A/en unknown
- 2003-04-11 NO NO20031694A patent/NO328465B1/no not_active IP Right Cessation
2008
- 2008-09-19 AR ARP080104109A patent/AR068527A2/es unknown
2013
- 2013-07-11 UY UY34901A patent/UY34901A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
RS50218B (sr)	2009-07-15
HK1060567A1 (en)	2004-08-13
HU226830B1 (en)	2009-11-30
EP1468998A1 (de)	2004-10-20
HRP20030276A2 (en)	2005-02-28
IS2339B (is)	2008-02-15
AU2002214996B2 (en)	2007-03-15
YU27303A (sh)	2006-05-25
ME00243B (me)	2011-05-10
HRP20030276B1 (en)	2006-02-28
BG66161B1 (bg)	2011-09-30
EP1326862A1 (de)	2003-07-16
TR200402579T4 (tr)	2004-12-21
PT1326862E (pt)	2004-11-30
KR20030042008A (ko)	2003-05-27
MY126931A (en)	2006-10-31
NZ525733A (en)	2005-01-28
KR100823860B1 (ko)	2008-04-21
WO2002030928A1 (de)	2002-04-18
AP1572A (en)	2006-02-13
EE04567B1 (et)	2005-12-15
AU1499602A (en)	2002-04-22
TW589313B (en)	2004-06-01
UA74215C2 (uk)	2005-11-15
CN100519558C (zh)	2009-07-29
CN1469877A (zh)	2004-01-21
ES2228965T3 (es)	2005-04-16
JP2004526668A (ja)	2004-09-02
NO328465B1 (no)	2010-02-22
ATE276253T1 (de)	2004-10-15
ECSP034540A (es)	2003-07-25
HK1086557A1 (zh)	2006-09-22
CA2425539C (en)	2007-04-03
GEP20063905B (en)	2006-08-25
CN1221549C (zh)	2005-10-05
CZ301841B6 (cs)	2010-07-07
AR034389A1 (es)	2004-02-25
MA25842A1 (fr)	2003-07-01
PL366041A1 (en)	2005-01-24
JP3764422B2 (ja)	2006-04-05
BR0114584A (pt)	2003-08-26
SK4362003A3 (en)	2003-08-05
DK1326862T3 (da)	2004-11-22
SA01220412B1 (ar)	2006-11-05
NO20031694D0 (no)	2003-04-11
EP1326862B1 (de)	2004-09-15
IS6772A (is)	2003-04-09
UY34901A (es)	2015-02-27
ZA200302500B (en)	2004-04-22
SK287009B6 (sk)	2009-09-07
HUP0301022A2 (hu)	2003-10-28
MEP40008A (en)	2011-02-10
DZ3478A1 (fr)	2002-04-18
IL155335A0 (en)	2003-11-23
EA200300457A1 (ru)	2003-10-30
PE20020422A1 (es)	2002-06-28
EA004381B1 (ru)	2004-04-29
CR6938A (es)	2004-10-28
SI1326862T1 (sl)	2005-02-28
UY26962A1 (es)	2002-06-20
EG24142A (en)	2008-08-06
BG107687A (bg)	2003-09-30
PL207870B1 (pl)	2011-02-28
MXPA03003221A (es)	2004-12-03
CN1733761A (zh)	2006-02-15
OA12403A (en)	2006-04-18
AP2003002775A0 (en)	2003-03-31
CA2425539A1 (en)	2003-04-11
EE200300171A (et)	2003-06-16
HUP0301022A3 (en)	2005-12-28
IL155335A (en)	2009-02-11
DE50103666D1 (de)	2004-10-21
AR068527A2 (es)	2009-11-18

Publication	Publication Date	Title
NO20031694L (no)	2003-04-11	Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
NO20035696D0 (no)	2003-12-19	Krystallinsk anti-cholinergikum, fremgangsmåte for fremstilling derav og anvendelse derav til fremstilling av et legemiddel
DK1144386T3 (da)	2004-01-12	Polymorf form af telmisartan, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddel
DK1345910T3 (da)	2009-07-20	Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
NO20015156D0 (no)	2001-10-22	5-pyridyl-1,3-Azol forbindelser, fremgangsmåte for produksjon av de samme og deres anvendelse
NO20030844L (no)	2003-02-25	Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav
AU2002345016A1 (en)	2003-06-19	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
NO20025879D0 (no)	2002-12-06	Acylfenylureaderivater, fremgangsmåte for fremstilling derav og deres anvendelse som et legemiddel
NO20024175D0 (no)	2002-09-02	Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
NO20022176D0 (no)	2002-05-07	Absorberende gjenstand og fremgangsmåte for fremstilling av denne
TWI345975B (en)	2011-08-01	Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
NO20025377D0 (no)	2002-11-08	FremgangsmÕte for fremstilling av dihydroksyestere og derivater derav
NO20015542D0 (no)	2001-11-13	Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
GB0017060D0 (en)	2000-08-30	Production, stabilisation and use of reduced forms of pharmaceutical compounds
EE200300537A (et)	2004-04-15	Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
NO20013880D0 (no)	2001-08-09	Matriks og fremgangsmate for fremstilling av polyolefin
FI20000780L (fi)	2001-10-04	Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
NO20030515D0 (no)	2003-02-03	Fremgangsmåte for fremstilling av dinapsolin
DK1053224T3 (da)	2002-12-23	Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
IS6456A (is)	2002-07-04	Ný aðferð til að búa til a-(2-4-dísúlfófenýl)-N-tert-bútýlnítrón og lyfjafræðilega viðurkennd sölt þess
DK1341758T3 (da)	2006-10-30	Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
NO20042022L (no)	2004-05-14	Fast legemiddelformulering som inneholder pipiperazinurea-derivat og fremgangsmate for fremstilling av formuleringen
EE200300045A (et)	2004-12-15	Kristalne ravimaine
IS7846A (is)	2005-05-13	Aðferð til að framleiða lyfjafræðilega virkt efnasamband og til að framleiða milliefni þess
NO20035839L (no)	2004-03-01	Krystallinsk form av et fenyletanolamin, fremstilling derav og farmasoytiske preparater inneholdende de samme

Legal Events

Date	Code	Title	Description
2021-10-11	MK1K	Patent expired